Pitt distinguished professor Bill Wagner discussed how new materials and techniques could change medical care in space.

Early results of the trial, which is part of a three-trial platform consortium spanning more than 300 hospitals worldwide, found that full doses of heparin, a blood thinner, were not only safe but also reduced the need for vital organ support, such as ventilation.

The National Institutes of Health has selected Pitt to lead a trio of Phase 3 clinical trials involving COVID-19 patients that will explore the use of blood thinners in saving lives and improving care.

Surgery is well-documented as a male-dominated field, and a recent School of Medicine study led by Sara Myers shows the issue isn’t surgical ability.

A new School of Medicine discovery in mice showed the innate immune system has "memory" that, when inhibited, lengthens organ transplant survival.

Pitt researcher Daniel Hall said as population ages, assessing risk is even more essential to ensure that surgery is offered to the right patients, consistent with their goals and values.

A multidisciplinary team led by Ron Poropatich is working on a specialized medical backpack for the U.S. Army that could help injured patients in the field survive until they reach a fully staffed hospital.

To address the critical need for long-lasting heart valve replacements, a team of Pitt researchers created a mesh that harnesses the body’s own healing power.

The question for regenerative medicine research is “‘What can we do in space that we can't do on Earth that makes a difference?’" said William Wagner, director of the McGowan Institute, which has joined with the International Space Station U.S. National Laboratory to look for answers. "That's a pretty exciting question, because it's currently unanswered."

An undergraduate research project in the Swanson School of Engineering sent alumnus Joe Pugar (’17) in a new career direction, as CEO of startup company Aruga Technologies.